BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Meet the Under-the-Radar Biotech With a ‘Novel’ Alzheimer’s Candidate

  As the world watches big pharma companies take on the challenges of developing a viable therapy for ALZ’s disease, smaller companies are also attempting to blaze a treatment trail in the neurodegenerative market.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Medtech Innovative Health Solutions to Create New Jobs in Expansion

  Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Why Bay Area’s Intuitive Surgical Could be the Top Medtech Stock Right Now

  Over the years, Intuitive Surgical has carved out a place for itself as one of the few providers of minimally-invasive, robotically-assisted surgical equipment.

  November 21, 2017

   · 

  1 min read
• 

  FDA

  The FDA Cleared 19 Spine Devices in October Alone

  A look at the 19 spine-related medical devices the FDA cleared in October.

  November 21, 2017

   · 

  1 min read
• 

  Job Trends

  Fresenius Kabi to Create Hundreds of New Jobs in North Carolina With $100M Expansion

  Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Unexpected Safety Issue Forces Bay Area’s Ardelyx to Ditch Phase III Hyperkalemia Drug

  Ardelyx updated two of its programs today.

  November 21, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  BioMidwest

  2 Rivals That Could Take a Chunk of Medtronic’s Heart-Unit Sales

  The company is expected to face growing competition from Abbott and Boston Scientific in heart implants, an analyst said.

  November 21, 2017

   · 

  1 min read
• 

  Drug Development

  Cytokinetics Scraps Lead ALS Drug After Late-Stage Trial Failure

  Cytokinetics has suspended development of tirasemtiv after it failed to differentiate itself from placebo in a statistically significant manner.

  November 21, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year

  Investors have had a decent year, but some have much to be grateful for this Thanksgiving.

  November 21, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year

  In less than four years, Corbus has grown from a tiny startup to a public company with 60 employees and four assets in the clinic.

  November 21, 2017

   · 

  4 min read

   · 

  Alex Keown